Target type: biologicalprocess
Any process that activates or increases the frequency, rate, or extent of an inflammatory response to an antigenic stimulus. [GOC:add]
Positive regulation of inflammatory response to antigenic stimulus is a complex biological process that involves a coordinated interplay of cells, signaling molecules, and effector mechanisms. It is essential for the host's defense against pathogens, but dysregulation of this process can lead to chronic inflammatory diseases.
The process begins with the recognition of an antigenic stimulus, such as a pathogen or a foreign molecule, by immune cells. This recognition is mediated by pattern recognition receptors (PRRs), which are expressed on the surface of cells like macrophages, dendritic cells, and neutrophils. PRRs recognize conserved molecular patterns associated with pathogens, such as lipopolysaccharide (LPS) or viral double-stranded RNA.
Upon recognition of the antigen, immune cells initiate a cascade of signaling events that lead to the activation of transcription factors, such as NF-κB and AP-1. These transcription factors regulate the expression of genes involved in inflammation, including pro-inflammatory cytokines like TNF-α, IL-1β, IL-6, and chemokines.
These cytokines act as messengers, attracting other immune cells to the site of infection or inflammation. They also induce the expression of adhesion molecules on the surface of blood vessels, allowing immune cells to adhere to the vessel wall and migrate into the infected tissue.
Once at the site of infection, neutrophils, macrophages, and other immune cells phagocytose and kill pathogens. They also release antimicrobial substances, such as reactive oxygen species and enzymes, that directly target pathogens.
The inflammatory response is tightly regulated to ensure that it is effective in eliminating the pathogen without causing excessive tissue damage. Negative regulators, such as anti-inflammatory cytokines (e.g., IL-10, TGF-β) and regulatory T cells, suppress inflammation once the pathogen has been cleared.
However, in some cases, the inflammatory response can become dysregulated, leading to chronic inflammation. This can occur due to persistent infection, autoimmune diseases, or environmental factors. Chronic inflammation is associated with an increased risk of developing various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.
In summary, positive regulation of inflammatory response to antigenic stimulus is a crucial process for host defense against pathogens. It involves a complex interplay of cells, signaling molecules, and effector mechanisms that lead to the activation of immune cells and the elimination of pathogens. However, dysregulation of this process can lead to chronic inflammation, which is associated with a range of diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Lysine--tRNA ligase | A eukaryotic-type lysine--tRNA ligase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15046] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
imatinib | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor | |
staurosporine | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector | |
dehydroabietic acid | dehydroabietate : A monocarboxylic acid anion that is the conjugate base of dehydroabietic acid, obtained by deprotonation of the carboxy group. dehydroabietic acid : An abietane diterpenoid that is abieta-8,11,13-triene substituted at position 18 by a carboxy group. dehydroabietic acid: major aquatic toxicant in effluent of pulp and paper mills | abietane diterpenoid; carbotricyclic compound; monocarboxylic acid | allergen; metabolite |
crizotinib | crizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. | 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
cladosporin | cladosporin: antifungal metabolite from Cladosporium cladosporioides; toxic, minor metabolite of Aspersillus flavus; inhibits tRNA synthetase in Plasmodium falciparum | ||
dehydroabietinol | dehydroabietinol: Isolated from Hyptis suaveolens; structure in first source | abietane diterpenoid; carbotricyclic compound | |
nvp-tae684 | piperidines |